Cargando…

Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis

OBJECTIVE: To determine how cohorting patients based on presenting complaints affects risk of nosocomial infection in crowded Emergency Departments (EDs) under conditions of high and low prevalence of COVID-19. METHODS: This was a retrospective analysis of presenting complaints and PCR tests collect...

Descripción completa

Detalles Bibliográficos
Autores principales: Bijur, Polly E., Friedman, Benjamin W., Baron, Sarah W., Ramasahayam, Abhiram, Nerenberg, Rebecca, Sharpe, Shellyann, Goldstein, D. Yitzchak, Esses, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818126/
https://www.ncbi.nlm.nih.gov/pubmed/35220142
http://dx.doi.org/10.1016/j.ajem.2022.01.070
_version_ 1784645766039470080
author Bijur, Polly E.
Friedman, Benjamin W.
Baron, Sarah W.
Ramasahayam, Abhiram
Nerenberg, Rebecca
Sharpe, Shellyann
Goldstein, D. Yitzchak
Esses, David
author_facet Bijur, Polly E.
Friedman, Benjamin W.
Baron, Sarah W.
Ramasahayam, Abhiram
Nerenberg, Rebecca
Sharpe, Shellyann
Goldstein, D. Yitzchak
Esses, David
author_sort Bijur, Polly E.
collection PubMed
description OBJECTIVE: To determine how cohorting patients based on presenting complaints affects risk of nosocomial infection in crowded Emergency Departments (EDs) under conditions of high and low prevalence of COVID-19. METHODS: This was a retrospective analysis of presenting complaints and PCR tests collected during the COVID-19 epidemic from 4 EDs from a large hospital system in Bronx County, NY, from May 1, 2020 to April 30, 2021. Sensitivity, specificity, positive and negative predictive value (PPV, NPV) were calculated for a symptom screen based on the CDC list of COVID-19 symptoms: fever/chills, shortness of breath/dyspnea, cough, muscle or body ache, fatigue, headache, loss of taste or smell, sore throat, nasal congestion/runny nose, nausea, vomiting, and diarrhea. PPV was calculated for varying values of prevalence. RESULTS: There were 80,078 visits with PCR tests. The sensitivity of the symptom screen was 64.7% (95% CI: 63.6, 65.8), specificity 65.4% (65.1, 65.8). PPV was 16.8% (16.5, 17.0) and NPV was 94.5% (94.4, 94.7) when the observed prevalence of COVID-19 in the ED over the year was 9.7%. The PPV of fever/chills, cough, body and muscle aches and nasal congestion/runny nose were each approximately 25% across the year, while diarrhea, nausea, vomiting and headache were less predictive, (PPV 4.7%–9.6%) The combinations of fever/chills, cough, muscle/body aches, and shortness of breath had PPVs of 40–50%. The PPV of the screen varied from 3.7% (3.6, 3.8) at 2% prevalence of COVID-19 to 44.3% (44.0, 44.7) at 30% prevalence. CONCLUSION: The proportion of patients with a chief complaint of COVID-19 symptoms and confirmed COVID-19 infection was exceeded by the proportion without actual infection. This was true when prevalence in the ED was as high as 30%. Cohorting of patients based on the CDC's list of COVID-19 symptoms will expose many patients who do not have COVID-19 to risk of nosocomially acquired COVID-19. EDs should not use the CDC list of COVID-19 symptoms as the only strategy to minimize exposure.
format Online
Article
Text
id pubmed-8818126
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88181262022-02-07 Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis Bijur, Polly E. Friedman, Benjamin W. Baron, Sarah W. Ramasahayam, Abhiram Nerenberg, Rebecca Sharpe, Shellyann Goldstein, D. Yitzchak Esses, David Am J Emerg Med Article OBJECTIVE: To determine how cohorting patients based on presenting complaints affects risk of nosocomial infection in crowded Emergency Departments (EDs) under conditions of high and low prevalence of COVID-19. METHODS: This was a retrospective analysis of presenting complaints and PCR tests collected during the COVID-19 epidemic from 4 EDs from a large hospital system in Bronx County, NY, from May 1, 2020 to April 30, 2021. Sensitivity, specificity, positive and negative predictive value (PPV, NPV) were calculated for a symptom screen based on the CDC list of COVID-19 symptoms: fever/chills, shortness of breath/dyspnea, cough, muscle or body ache, fatigue, headache, loss of taste or smell, sore throat, nasal congestion/runny nose, nausea, vomiting, and diarrhea. PPV was calculated for varying values of prevalence. RESULTS: There were 80,078 visits with PCR tests. The sensitivity of the symptom screen was 64.7% (95% CI: 63.6, 65.8), specificity 65.4% (65.1, 65.8). PPV was 16.8% (16.5, 17.0) and NPV was 94.5% (94.4, 94.7) when the observed prevalence of COVID-19 in the ED over the year was 9.7%. The PPV of fever/chills, cough, body and muscle aches and nasal congestion/runny nose were each approximately 25% across the year, while diarrhea, nausea, vomiting and headache were less predictive, (PPV 4.7%–9.6%) The combinations of fever/chills, cough, muscle/body aches, and shortness of breath had PPVs of 40–50%. The PPV of the screen varied from 3.7% (3.6, 3.8) at 2% prevalence of COVID-19 to 44.3% (44.0, 44.7) at 30% prevalence. CONCLUSION: The proportion of patients with a chief complaint of COVID-19 symptoms and confirmed COVID-19 infection was exceeded by the proportion without actual infection. This was true when prevalence in the ED was as high as 30%. Cohorting of patients based on the CDC's list of COVID-19 symptoms will expose many patients who do not have COVID-19 to risk of nosocomially acquired COVID-19. EDs should not use the CDC list of COVID-19 symptoms as the only strategy to minimize exposure. Elsevier Inc. 2022-04 2022-02-06 /pmc/articles/PMC8818126/ /pubmed/35220142 http://dx.doi.org/10.1016/j.ajem.2022.01.070 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bijur, Polly E.
Friedman, Benjamin W.
Baron, Sarah W.
Ramasahayam, Abhiram
Nerenberg, Rebecca
Sharpe, Shellyann
Goldstein, D. Yitzchak
Esses, David
Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis
title Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis
title_full Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis
title_fullStr Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis
title_full_unstemmed Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis
title_short Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis
title_sort should covid-19 symptoms be used to cohort patients in the emergency department? a retrospective analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818126/
https://www.ncbi.nlm.nih.gov/pubmed/35220142
http://dx.doi.org/10.1016/j.ajem.2022.01.070
work_keys_str_mv AT bijurpollye shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis
AT friedmanbenjaminw shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis
AT baronsarahw shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis
AT ramasahayamabhiram shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis
AT nerenbergrebecca shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis
AT sharpeshellyann shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis
AT goldsteindyitzchak shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis
AT essesdavid shouldcovid19symptomsbeusedtocohortpatientsintheemergencydepartmentaretrospectiveanalysis